ArticlePatient preference and adherence2019

Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections.

Johanna Mucke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.